Avanos Medical, Inc. (NYSE:AVNS) Short Interest Down 5.2% in January

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) saw a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 632,000 shares, a decrease of 5.2% from the January 15th total of 666,900 shares. Approximately 1.4% of the company's shares are short sold. Based on an average daily volume of 444,200 shares, the short-interest ratio is currently 1.4 days.

Avanos Medical Trading Up 0.0 %

Shares of Avanos Medical stock traded up $0.01 during trading on Friday, reaching $15.49. 350,491 shares of the stock were exchanged, compared to its average volume of 545,288. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The stock's fifty day moving average is $16.27 and its 200 day moving average is $19.92. The firm has a market cap of $711.78 million, a price-to-earnings ratio of 45.55 and a beta of 0.98. Avanos Medical has a 1 year low of $14.98 and a 1 year high of $25.36.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.

Institutional Trading of Avanos Medical

A number of institutional investors have recently modified their holdings of AVNS. Quarry LP purchased a new stake in Avanos Medical in the third quarter worth about $42,000. Quantbot Technologies LP purchased a new stake in Avanos Medical in the fourth quarter worth about $64,000. KBC Group NV lifted its holdings in Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company's stock worth $68,000 after buying an additional 1,095 shares during the period. State of Wyoming lifted its holdings in Avanos Medical by 132.0% in the fourth quarter. State of Wyoming now owns 5,137 shares of the company's stock worth $82,000 after buying an additional 2,923 shares during the period. Finally, Tower Research Capital LLC TRC lifted its holdings in Avanos Medical by 493.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock worth $129,000 after buying an additional 6,714 shares during the period. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.